Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Net Margin (2020 - 2025)

Historic Net Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 12.74%.

  • Burning Rock Biotech's Net Margin rose 150600.0% to 12.74% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.38%, marking a year-over-year increase of 631100.0%. This contributed to the annual value of 64.92% for FY2024, which is 567100.0% up from last year.
  • Per Burning Rock Biotech's latest filing, its Net Margin stood at 12.74% for Q3 2025, which was up 150600.0% from 6.53% recorded in Q2 2025.
  • Over the past 5 years, Burning Rock Biotech's Net Margin peaked at 6.53% during Q2 2025, and registered a low of 200.36% during Q2 2022.
  • In the last 5 years, Burning Rock Biotech's Net Margin had a median value of 133.97% in 2023 and averaged 110.6%.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -577000bps in 2021, then skyrocketed by 1106300bps in 2023.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Net Margin stood at 170.44% in 2021, then grew by 11bps to 152.02% in 2022, then rose by 12bps to 133.97% in 2023, then skyrocketed by 58bps to 56.07% in 2024, then skyrocketed by 77bps to 12.74% in 2025.
  • Its last three reported values are 12.74% in Q3 2025, 6.53% for Q2 2025, and 10.15% during Q1 2025.